MariaLDelioukinaMD

PubMed

• 1 citations
  Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.
  Philippe Moreau, Ajai Chari, Albert Oriol, Joaquin Martinez-Lopez, Mathias Haenel, Cyrille Touzeau, Sikander Ailawadhi, Britta Besemer, Javier de la Rubia Comos, Crist...> ;Blood Cancer Journal. 2023 Mar 7
• 17 citations
  Final analysis of the phase III non-inferiority COLUMBA study of subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma.
  Saad Z Usmani, Hareth Nahi, Wojciech Legiec, Sebastian Grosicki, Vladimir Vorobyev, Ivan Spicka, Vania Hungria, Sibirina Korenkova, Nizar J Bahlis, Max Flogegard, Joan...> ;Haematologica. 2022 Oct 1
• 4 citations
  Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma.
  Maria-Victoria Mateos, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Rik Schots, Tomasz Wrobel, Gordon Cook, Meral Beksac, Katharine S Gries, Anupa Kudva, Brenda Tromp...> ;Journal of Oncology Pharmacy Practice. 2023 Jul 1
• 100 citations
  Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a ra...
  Thierry Facon, Shaji Kumar, Torben Plesner, Robert Z. Orlowski, Philippe Moreau, Nizar J. Bahlis, Supratik Basu, Hareth Nahi, Cyrille Hulin, Hang Quach, Hartmut Goldsc...> ;The Lancet. Oncology. 2021 Oct 13
• 37 citations
  Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study
  Ajai Chari, Paula Rodriguez-Otero, Helen McCarthy, Kenshi Suzuki, Vania Hungria, Anna Sureda Balari, Aurore Perrot, Cyrille Hulin, Hila Magen, Shinsuke Iida, Vladimir ...> ;British Journal of Haematology. 2021 Mar 1
• 88 citations
  Ibrutinib plus lenalidomide and rituximab has promising activity in relapsed/refractory non-germinal center B-cell-like DLBCL
  Andre Goy, Radhakrishnan Ramchandren, Nilanjan Ghosh, Javier Munoz, David S. Morgan, Nam H. Dang, Mark Knapp, Maria Delioukina, Edwin C. Kingsley, Jerry Ping, Darrin M...> ;Blood. 2019 Sep 26
• A Rare Case of Primary Gastric HIV-Associated Peripheral T-Cell Lymphoma: Relapsed Disease Treated With Pemetrexed
  Jun Gong, Maria Delioukina, Andrew Eugene Hendifar> ;World Journal of Oncology. 2013 Sep 27
• 98 citations
  Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma
  Steven M. Horwitz, Youn H. Kim, Francine M. Foss, Jasmine Zain, Patricia L. Myskowski, Mary Jo Lechowicz, David C. Fisher, Andrei R. Shustov, Nancy L. Bartlett, Maria ...> ;Blood. 2012 May 3
• 20 citations
  A phase I study in adults of clofarabine combined with high-dose melphalan as reduced-intensity conditioning for allogeneic transplantation.
  Mark Kirschbaum, Anthony S. Stein, Leslie Popplewell, Maria Delioukina, Robert T. Chen, Ryotaro Nakamura, David S. Snyder, Joel Conrad, Simon F. Lacey, Paul Frankel, A...> ;Biology of Blood and Marrow Transplantation. 2012 Mar 1
• 36 citations
  Reduced Intensity Allogeneic Hematopoietic Cell Transplantation using Fludarabine-Melphalan conditioning for Treatment of Mature T-cell Lymphomas
  Maria Delioukina, Jasmine Zain, Joycelynne Palmer, Nicole Tsai, Sandra H. Thomas, Stephen J. Forman> ;Bone Marrow Transplantation. 2012 Jan 1
• 29 citations
  High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphoma (PTCL): Analysis of Prognostic Factors
  Auayporn Nademanee, Joycelynne Palmer, Leslie Popplewell, Ni-Chun Tsai, Maria Delioukina, Karl Gaal, Ji-Lian Cai, Neil Kogut, Stephen J. Forman> ;Biology of Blood and Marrow Transplantation. 2011 Oct 1
• 30 citations
  Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control.
  Jasmine Zain, Joycelynne Palmer, Maria Delioukina, Sandra H. Thomas, Ni-Chun Tsai, Auayporn Nademanee, Leslie Popplewell, Karl Gaal, David Senitzer, Neil Kogut, Margar...> ;Leukemia & Lymphoma. 2011 Jul 14
• Pharmacokinetics (PK) and pharmacodynamics (PD) of RG7112, an oral murine double minute 2 (MDM2) antagonist, in patients with leukemias and solid tumors.
  Beryozkina A, Nichols GL, Reckner M, Vassilev LT, Rueger R, Jukofsky L, Middleton S, Andreeff M, Padmanabhan S, Strair R, Delioukina ML, Maslak PG, Hillmen P, Kurzrock...> ;J. Clin. Oncol.. 2011-05-20
• 34 citations
  Molecular Karyotypes of Hodgkin and Reed–Sternberg Cells at Disease Onset Reveal Distinct Copy Number Alterations in Chemosensitive versus Refractory Hodgkin Lymphoma
  Marilyn L. Slovak, Victoria Bedell, Ya-Hsuan Hsu, Dolores B. Estrine, Norma J. Nowak, Maria Delioukina, Lawrence M. Weiss, David D. Smith, Stephen J. Forman> ;Clinical Cancer Research. 2011 May 15
• 5 citations
  Allogeneic hematopoietic cell transplant with fludarabine-based reduced-intensity conditioning as treatment for advanced chronic lymphocytic leukemia.
  Maria Delioukina, Joycelynne Palmer, Sandra H. Thomas, Amrita Krishnan, Tracey Stiller, Stephen J. Forman> ;Leukemia & Lymphoma. 2011 Mar 25
• 156 citations
  Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
  Mark Kirschbaum, Paul Frankel, Leslie Popplewell, Jasmine Zain, Maria Delioukina, Vinod Pullarkat, Deron Matsuoka, Bernadette Pulone, Arnold J. Rotter, Igor Espinoza-D...> ;Journal of Clinical Oncology. 2011 Mar 20
• 8 citations
  Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis
  Roger A. Schultz, Maria Delioukina, Karl Gaal, Victoria Bedell, David D. Smith, Stephen J. Forman, Lisa D. McDaniel, Blake C. Ballif, Lisa G. Shaffer, Marilyn L. Slovak> ;Molecular Cytogenetics. 2011 Feb 3
• 28 citations
  Reduced intensity allogeneic hematopoietic cell transplantation can induce durable remission in heavily pretreated relapsed Hodgkin lymphoma
  Robert T. Chen, Joycelynne Palmer, Leslie Popplewell, Jessica Shen, Eileen P. Smith, Maria Delioukina, Neil Kogut, Joseph Rosenthal, Stephen J. Forman, Auayporn Nademanee> ;Annals of Hematology. 2011 Jan 6
• ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?
  Maria Delioukina, Stephen J. Forman> ;Mediterranean Journal of Hematology and Infectious Diseases. 2010 Jun 30
• 14 citations
  Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma
  Maria L. Delioukina, Diane Prager, Mandy Parson, J. Randolph Hecht, Peter Rosen, Lee S. Rosen> ;Cancer. 2002 Apr 15
• Circadian function in patients with advanced non-small-cell lung cancer.
  Levin, R. D., Daehler, M. A., Grutsch, J. F., Quiton, J., Lis, C. G., Peterson, C., Gupta, D., Watson, K., Layer, D., Huff-Adams, S., Desai, B., Sharma, P., Wallam, M....> ;Br J Cancer. 2005 Nov 28
• Successful allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia in a patient with hepatic echinococcal cyst managed by delayed hepatectomy.
  Kim, J., Delioukina, M. L., Lee, W., Soriano, P., Prendergast, C., D'Apuzzo, M., Dadwal, S. S.> ;Transpl Infect Dis. 2011 Jun
• Join now to see all